Prostate Links

LUPRON DEPOT® (leuprolide acetate for depot suspension) 7.5 mg, −3 Month 22.5 mg and −4 Month 30 mg are prescribed for the palliative treatment of advanced prostate cancer.

An increase in urinary symptoms and/or pain may occur during the first few weeks of LUPRON DEPOT treatment. In patients whose cancer has spread to the spine or urinary tract, urinary blockage or pressure in the spine may occur and can lead to paralysis, which may be fatal. LUPRON DEPOT may cause impotence. Females who are or may become pregnant should not receive LUPRON DEPOT.

Please click here for additional Important Safety Information you should know about LUPRON DEPOT and discuss with your doctor.

There is a lot to know about prostate cancer. The following Web sites provide information about prostate cancer, prostate disease, and treatment options.

Abbott Laboratories cannot assure the accuracy or timeliness of the information available at the following Web sites and information resources.

American Association for Cancer Research (AACR)

www.aacr.org
The American Association for Cancer Research provides research grants and publishes several medical journals.

American Cancer Society (ACS)
(800) 227-2345

www.cancer.org
The American Cancer Society (ACS) can be a starting point for supporting family members and dealing with other issues that may arise after a prostate cancer diagnosis. The site also includes information about the ACS and statistics about prostate cancer incidence rates.

Center for Prostate Disease Research (CPDR)

www.cpdr.org
The CPDR is a prostate cancer research program funded by the U.S. Army that conducts research nationwide at U.S. Army, Navy, and Air Force hospitals. The site explains the program and provides education and research updates.

CoPays.org

www.copays.org
You may be eligible for Patient Advocate Foundation’s Co-Pay Relief (CPR) Program, which provides direct co-payment assistance for pharmaceutical products to insured Americans who financially and medically qualify. The program offers personal service to all patients through the use of CPR call counselors.

National Cancer Institute (NCI)
(800) 422-6237

www.cancer.gov
This useful gateway into the National Cancer Institute allows you to access a portion of the contents of PDQ—the Physician Data Query database. With detailed information about specific cancers, PDQ is written for both medical professionals and patients.

National Coalition for Cancer Survivorship (NCCS)
(877) 622-7937

www.canceradvocacy.org
The National Coalition for Cancer Survivorship is a grassroots network of individuals and organizations working on behalf of people with all types of cancer.

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

www.niddk.nih.gov
The NIDDK, under the auspices of the National Institutes of Health, provides a site with answers to questions about BPH and prostatitis.

Lo Que Usted Necesita Saber Sobre™ el Cáncer de Próstata

www.cancer.gov/espanol/sabersobre/prostata
Este folleto del Instituto Nacional del Cáncer (NCI) contiene información importante acerca del cáncer de próstata.

Prostate Cancer Foundation (PCF)
(800) 757-2873

www.prostatecancerfoundation.org
Prostate Cancer Foundation (PCF), an organization dedicated to finding a cure for prostate cancer, is the largest private source for research funding for prostate cancer. They offer information on prostate cancer, treatment options, clinical trials, and personal stories of survival.


Use and Important Safety Information you should know about Lupron Depot® (leuprolide acetate for depot suspension)


Use

LUPRON DEPOT® (leuprolide acetate for depot suspension) 7.5 mg, −3 Month 22.5 mg and −4 Month 30 mg are prescribed for the palliative treatment of advanced prostate cancer.

Important Safety Information

Do not take LUPRON DEPOT if you have experienced any type of allergic reaction to LUPRON DEPOT or similar drugs.

LUPRON DEPOT 7.5 mg, −3 Month 22.5 mg and −4 Month 30 mg should not be used in women.

An increase in testosterone will generally occur during the first few weeks of therapy. In some men, this may cause a temporary increase in urinary symptoms and/or pain. If your cancer has spread to the spine or urinary tract, you may require close medical attention during the first few weeks of therapy. You should also know that LUPRON DEPOT may cause impotence. You should notify your doctor if you develop any new or worsened symptoms after beginning LUPRON DEPOT treatment.

It is recommended that your PSA and serum testosterone levels be monitored at regular intervals.

The most common side effects of LUPRON DEPOT include hot flashes or sweats, injection site reactions, general pain, edema, testicular atrophy, urinary disorders, joint disorder and GI disorders.

LUPRON DEPOT must be administered in your doctor’s office.

This is the most important information to know about LUPRON DEPOT. For more information, talk with your health care provider.

Reference: LUPRON DEPOT 7.5 mg, −3 Month 22.5 mg and −4 Month 30 mg [package insert]. North Chicago, IL: Abbott Laboratories.

Please see the complete Prescribing Information for Lupron Depot.

Lupron Depot is available by prescription only.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088 (1-800-332-1088).
If you cannot afford your medication, contact www.pparx.org or call the
toll-free phone number (1-888-4PPA-NOW) (1-888-477-2669) for assistance.

200-263312